ASSOCIATED BANC-CORP
For the period ended Sep 30, 2026. Filed Oct 27, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 27, 2026
ASB$30.89+1.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (Unaudited)
| Nine Months Ended Sep 30, | ||
|---|---|---|
| (in thousands) | 2026 | 2025 |
| Cash flows from operating activities | ||
| Net income | $389,785 | $337,648 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Provision for credit losses | 44,394 | 46,999 |
| Depreciation and amortization | 36,857 | 37,959 |
| Change in MSRs valuation | (6,670) | 2,464 |
| Amortization of other intangible assets | 15,990 | 6,608 |
| Amortization and accretion on earning assets, funding, and other, net | 18,398 | 30,520 |
| Net amortization of tax credit investments | 25,623 | 26,307 |
| Loss on sales of investment securities, net | 4 | — |
| Asset losses, net | (4,305) | (727) |
| Loss on mortgage banking activities, net | 4,686 | 103 |
| Loss on mortgage portfolio sale | — | 6,976 |
| Net periodic pension benefit | (18,463) | (18,540) |
| Mortgage loans originated for sale | (541,424) | (470,456) |
| Proceeds from sales of mortgage loans held for sale | 546,342 | 451,869 |
| Changes in certain assets and liabilities: | ||
| Increase in interest receivable | (2,577) | (678) |
| Increase in BOLI/COLI cash surrender value | (13,122) | (13,391) |
| Decrease in net income tax position | 60,622 | 69,984 |
| Decrease in interest payable | (3,883) | (28,163) |
| Decrease in expense payable | (26,232) | (18,790) |
| Decrease (increase) in net derivative position | 128,297 | (63,192) |
| Net change in other assets and other liabilities | 17,829 | (5,890) |
| Net cash provided by operating activities | 672,151 | 397,610 |
| Cash flows from investing activities | ||
| Net increase in loans | (1,655,909) | (1,224,724) |
| Purchases of: | ||
| AFS securities | (2,131,161) | (1,355,308) |
| HTM securities | — | (994) |
| Regulatory stocks and equity securities | (176,316) | (187,426) |
| Proceeds from: | ||
| Sales of AFS securities | 995,831 | — |
| Sales of HTM securities | 1,221 | — |
| Sales of regulatory stocks and equity securities | 124,515 | 112,964 |
| Prepayments, calls, and maturities of AFS securities | 1,100,423 | 761,540 |
| Prepayments, calls, and maturities of HTM securities | 141,438 | 106,160 |
| Sales, prepayments, calls, and maturities of other assets | 37,275 | 18,929 |
| Sale of mortgage portfolio | — | 564,375 |
| Premises, equipment, and software | (29,958) | (28,591) |
| Net change in tax credit and alternative investments | (16,784) | (16,800) |
| Net cash received from the American National acquisition | 220,898 | — |
| Net cash used in investing activities | (1,388,527) | (1,249,875) |
| Cash flows from financing activities | ||
| Net increase in deposits | 283,142 | 233,419 |
| Net decrease in short-term funding | (55,856) | (70,704) |
| Net increase in short-term FHLB advances | 557,250 | 1,560,000 |
| Repayment of long-term FHLB advances | (202,516) | (400,198) |
| Proceeds from long-term FHLB advances | 300,000 | 200,898 |
| Repayment of finance lease principal | — | (67) |
| Repayment of long-term funding | — | (250,000) |
| Proceeds from issuance of common stock for stock-based compensation plans | 14,796 | 4,876 |
| Purchase of treasury stock, open market purchases | (125,202) | (22,292) |
| Purchase of treasury stock, stock-based compensation plans | (8,389) | (6,256) |
| Cash dividends on common stock | (130,976) | (115,566) |
| Cash dividends on preferred stock | (8,625) | (8,625) |
| Payments for other financing activities | — | (52) |
| Net cash provided by financing activities | 623,624 | 1,125,433 |
| Net (decrease) increase in cash and cash equivalents | (92,752) | 273,168 |
| Cash and cash equivalents at beginning of period | 1,720,221 | 1,019,604 |
| Cash and cash equivalents at end of period | $1,627,469 | $1,292,772 |
Consolidated Statements of Cash Flows
| Nine Months Ended Sep 30, | ||
|---|---|---|
| (in thousands) | 2026 | 2025 |
| Supplemental disclosures of cash flow information | ||
| Cash paid for interest | $730,605 | $763,622 |
| Issuance of common stock as consideration for the American National acquisition | 594,144 | — |
| Assets acquired from the American National acquisition | 5,228,544 | — |
| Liabilities assumed from the American National acquisition | 4,634,400 | — |
| Loans transferred to (from) held for sale from (into) portfolio, net | 4,878 | (54,339) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.